Severing the scar supply line: CAR-T in chronic kidney disease
Cell Stem Cell · 2025
DOI: 10.1016/j.stem.2025.08.002 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Stem Cell, 2025. Verfasst von Longwei Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Alfred E. Mann Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA; Depa…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Cicatrix. Die Arbeit nennt 10 Literaturangaben. Gefördert von: NIBIB NIH HHS, NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
CAR-T cell therapy is rapidly being extended to target various pathophysiological processes beyond cancer. In this issue of Cell Stem Cell, Zhao et al. engineered PDGFRβ-specific CAR-T cells in vivo to selectively target extracellular matrix-producing cells in kidney fibrosis,1 opening new opportunities for treating fibrotic diseases with precision immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Alfred E. Mann Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA; Department of Ophthalmology, Roski Eye Institute, Keck School of Medicine,…
- The Alfred E. Mann Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA. Electronic address: ywang283@usc.edu.
Förderung
- NIBIB NIH HHS
- NIGMS NIH HHS
- NIH
Zitieren
APA
Liu, L., & Wang, Y. (2025). Severing the scar supply line: CAR-T in chronic kidney disease. Cell Stem Cell. https://doi.org/10.1016/j.stem.2025.08.002
Vancouver
Liu L, Wang Y. Severing the scar supply line: CAR-T in chronic kidney disease. Cell Stem Cell. 2025. doi:10.1016/j.stem.2025.08.002
BibTeX
@article{Liu2025,
author = {Liu, Longwei and Wang, Yingxiao},
title = {Severing the scar supply line: CAR-T in chronic kidney disease},
journal = {Cell Stem Cell},
year = {2025},
doi = {10.1016/j.stem.2025.08.002}
}
EUVIMED